Реноваскулярна хвороба. Сучасний підхід до діагностики та лікування

В.Ю. Кундін, М.В. Сатир, А.В. Хохлов, А.Г. Мазур, І.В. Новерко, М.В. Шиманко


1. Abela R, Ivanova S, Lidder S. et al. An analysis comparing opensurgical and endovascular treatment of atherosclerotic renal artery stenosis. Eur J Vasc Endovasc Surg. 2009;38(6):666–675.
2. American Society for Testing and Materials (ASTM) International. ASTM F2503-05: Standard Practice for Marking Medical Devices and Other Items for Safety in the Magnetic Resonance Environment. West Conshohocken, Pa: ASTM International; 2005. Available at: http://www.astm.org.
3. Angeretti MG, Lumia D, Canì A. et al. Non-enhanced MR angiography of renal arteries: comparison with contrast-enhanced MR angiography. Acta Radiol. 2013;54 (7):749–756.
4. Balzer KM, Pfeiffer T, Rossbach S. et al. Prospective randomized trial of operative vs interventional treatment for renal artery ostial occlusive disease (RAOOD). J Vasc Surg. 2009;49(3):667–674.
5. Baumgartner I, Lerman LO. Renovascular hypertension: screening and modern management. Eur Heart J. 2011;32(13):1590–1598.
6. Bax L, Woittiez A.J, Kouwenberg H.J. et al. STAR Stent Placement in Patients With Atherosclerotic Renal Artery Stenosis and Impaired Renal Function. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann Intern Med. 2009;150(12):840–848.
7. Bertino RE, Bluth EI, Frates MC. et al. AIUM practice guideline for the performance of renal artery duplex sonography. J Ultrasound Med. 2009;28(1):120–124.
8. Bhave G, Lewis JB, Chang SS. Association of gadolinium based magnetic resonance imaging contrast agents and nephrogenic systemic fibrosis. J Urol. 2008;180(3):830–835.
9. Bloch M.J, Basile J. The diagnosis and management of renovascular disease: aprimary careperspective. Part I. Making thediagnosis. J Clin Hypertens (Greenwich). 2003;5(3):210–218.
10. Caielli P, Frigo AC, Pengo MF. et al. DRASTIC Dutch Renal Artery Stenosis Intervention Cooperative Study Treatment of atherosclerotic endovascular hypertension: review of observational studies and a meta-analysis of randomized clinical trials. Nephrol Dial Transplant. 2015;30(4):541–553.
11. Chi YW, White CJ, Thornton S, Milani RV. Ultrasound velocity criteria for renal in-stent restenosis. J Vasc Surg. 2009;50(1):119–123.
12. Cooper CC, Murphy TP, Cutlip DE. et al. and CORAL Investigators CORAL Cardiovascular Outcomesin Renal Atherosclerotic Lesions. Stenting and Medical Therapy for Atherosclerotic Renal-Artery Stenosis. New Engl J Med. 2014;370(1):13–22.
13. Drieghe B, Madaric J, Sarno G.et al. Assessment of renal artery stenosis: side-by-side comparison of angiography and duplex ultrasound with pressure gradient measurements. Eur Heart J. 2008;29:517–524.
14. Eklöf H, Ahlström H, Magnusson A. et al. A prospective comparison of duplex ultrasonography, captopril renography, MRA, and CTA in assessing renal artery stenosis. Acta Radiol. 2006;47(8):764–774.
15. Garovic VD, Textor SC. Renovascular hypertension and ischemic nephropathy. Circulation. 2005;112(9):1362–1364.
16. García-Criado A, Gilabert R, Nicolau C. et al. Value of Doppler sonography for predicting clinical outcome after renal artery revascularization in atherosclerotic renal artery stenosis. J Ultrasound Med. 2005;24(12):1641–1647.
17. Greco BA, Breyer JA. Atherosclerotic ischemic renal disease. Am J Kidney Dis. 1997;29(2):167–187.
18. Hackam DG, Duong-Hua ML, Mamdani M. et al. Angiotensin inhibition in renovascular disease: a population-based cohort study. Am Heart J. 2008;156(3):549–555.
19. Herrmann SMS, Textor SC. Diagnostic criteria for renovascular disease: where are we now? Nephrol Dial Transplant. 2012;27(7):2657–2663.
20. Hirsch AT, Haskal ZJ, Hertzer NR. et al. ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease) – summary of recommendations. J Vasc Interv Radiol. 2006;17(9):1383–1397.
21. Katritsis DG, Gersh BJ, Camm AJ. Clinical Cardiology: Current Practice Guidelines: updated edition. Oxford University Press 2016. 1008 p.
22. Leiner T, de Haan MW, Nelemans PJ. et al. Contemporary imaging techniques for the diagnosis of renal artery stenosis. Eur Radiol. 2005;15(11):2219–2229.
23. Levine GN, Gomes AS, Arai AE. et al. Safety of Magnetic Resonance Imaging in Patients With Cardiovascular Devices. Circulation. 2007;116:2878–2891.
24. Mailloux LU. Atherosclerotic ischemic renal vascular disease: do published outcomes justify the overzealous diagnostic approaches? Semin Nephrol. 2003;23(3):278–282.
25. Plouin PF. Stable patients with atherosclerotic renal artery stenosis should be treated first with medical management. Am J Kidney Dis. 2003;42(5):851–857.
26. Prasad S, Bannister K, Taylor J. Is magnetic resonance angiography useful in renovascular disease? Intern Med J. 2003;33(3):84–90.
27. Prince MR, Schoenberg SO, Ward JS. et al. Hemodynamically significant atherosclerotic renal artery stenosis: MR angiographic features. Radiology. 1997;205(1):128–136.
28. Radermacher J, Chavan A, Bleck J. et al. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. New Engl J Med. 2001;344(6):410–417.
29. Rountas C, Vlychou M, Vassiou K. et al. Imaging modalities for renal artery stenosis in suspected renovascular hypertension: prospective intraindividual comparison of color Doppler US, CT angiography, GD-enhanced MR angiography, and digital substraction angiography. Ren Fail. 2007;29(3):295–302.
30. Safian RD, Madder RD. Refining the approach to renal artery revascularization. JACC Cardiovasc Interv. 2009;2(3):161–174.
31. Sahin S, Cimşit C, Andaç N. et al. Renal artery stenting in solitary functioning kidneys: technical and clinical results. Eur J Radiol. 2006;57(1):131–137.
32. Santos S, Leite LR, Tse TS. et al. Renal resistance index predicting outcome of renal revascularization for renovascular hypertension. Arq BrasCardiol. 2010;94(4):452–456.
33. Schäberle W, Leyerer L, Schierling W, Pfister K. Ultrasound diagnostics of renal artery stenosis. Stenosis criteria, CEUS and recurrent in-stent stenosis. Gefasschirurgie. 2016;21:4–13.
34.Shellock FG, Crues JV. MR Safety and the American College of Radiology White Paper. Am J Roentgenol. 2002;178(6):1349–1352.
35. Spyridopoulos TN, Kaziani K, Balanika AP. et al. Ultrasound as a first line screening tool for the detection of renal artery stenosis: a comprehensive review. Med Ultrason. 2010;12(3):228–232.
36. Tendera M, Aboyans V, Bartelink ML. 2011 ESC Guidelines on the diagnosis and treatment of peripheral artery diseases. Eur Heart J. 2011;32:2851–2906.
37. Vasbinder GB, Nelemans PJ, Kessels AG. et al. Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: a meta-analysis. Ann Intern Med. 2001;135(6):401–411.
38. Vasbinder GB, Nelemans PJ, Kessels AG. et al. Accuracyofcomputedtomographicangiographyandmagneticresonanceangiographyfordiagnosingrenalarterystenosis. Ann Intern. Med. 2004;141(9):674–682.
39. Wheatley K, Ives N, Gray R, Kalra PA. et al. ASTRAL Investigators. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009;361(20):1953–1962.
40. White CJ, Jaff MR, Haskal ZJ. et al. Indications for renal arteriography at the time of coronaryarteriography: a science advisory from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Councilon Clinical Cardiology, and the Councilson Cardiovascular Radiology and Interventionand on Kidney in Cardiovascular Disease. Circulation. 2006;1140:1892–1895.


[PDF] [Зміст журналу]